Efficacy and safety of trimetazidine after percutaneous coronary intervention

A trial of trimetazidine in more than 6,000 patients who had undergone successful percutaneous coronary intervention.
A trial of trimetazidine in more than 6,000 patients who had undergone successful percutaneous coronary intervention.